Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019
Authors:
Top Cited Papers
- 26 September 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (4) , 615-625
Abstract
The burden of digestive cancers is increasing worldwide. The Global Cancer Observatory (GLOBOCAN) 2020 and the Global Burden of Disease (GBD) 2019 are two primary cancer databases, which have a significant impact on policy formulation and resource allocation. We aim to compare the incidence and mortality of digestive cancers between them. Digestive cancer (esophageal, stomach, colorectal, liver, gallbladder and pancreatic cancer) incidence was obtained from the Cancer Today and GBD 2019 result tool. The top five countries with the most or minor difference between GLOBOCAN 2020 and GBD 2019 in age‐standardized incidence rates (ASIRs) of digestive cancers were identified. A systematic search on the incidence of specific digestive cancer in selected countries from PubMed and Embase was conducted, and 20 of 281 publications were included. The most significant differences in digestive cancers incidence were commonly found in Asian countries (70%), particularly Indonesia, Vietnam and Myanmar, located in Southeast Asia. The ASIRs for most digestive cancers, except liver cancer, in GLOBOCAN 2020 were higher than those in GBD 2019. Gallbladder cancer had the highest average ratio, followed by liver cancer. The most commonly used standard population was Segi's standard population, followed by the World Health Organization standard population. The data sources nor the processing methods of GLOBOCAN 2020 and GBD 2019 were not similar. Low‐ and middle‐income countries without population‐based cancer registries were more likely to have selection bias in data collection and amplify regional variations of etiological factors. Better judgments on the quality of cancer data can be made.Keywords
Funding Information
- National Natural Science Foundation of China (81970495)
- Natural Science Foundation of Beijing (7202161)
This publication has 48 references indexed in Scilit:
- An assessment of GLOBOCAN methods for deriving national estimates of cancer incidenceBulletin of the World Health Organization, 2016
- EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluationEuropean Journal of Cancer, 2015
- Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisalJournal of the Royal Society of Medicine, 2015
- Cancer registration in P akistan: A dilemma that needs to be resolvedInternational Journal of Cancer, 2014
- The impact of economic growth on health care utilization: a longitudinal study in rural VietnamInternational Journal for Equity in Health, 2013
- Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality AssuranceCurrent Problems in Cancer, 2012
- Oral cancer in Myanmar: a preliminary survey based on hospital-based cancer registriesJournal of Oral Pathology & Medicine, 2010
- Incidence and survival of stomach cancer in a high-risk population of ChileWorld Journal of Gastroenterology, 2009
- Health financing for the poor produces promising short-term effects on utilization and out-of-pocket expenditure: evidence from VietnamInternational Journal for Equity in Health, 2009
- Content analysis: What are they talking about?Computers & Education, 2006